Imagine a sudden break-in to your skin caused by bacteria. But in this case, “the security system overreacts — alarms blare, sprinklers flood the rooms, and walls may even be torn down in the process of trying to stop the threat. That’s what happens during a skin infection caused by group A Streptococcus, or GAS,” explains David J. Gonzalez, an associate professor of Pharmacology and Pharmacy at the University of California, San Diego, or UCSD.

Global health estimates indicate that GAS causes 500 million infections worldwide each year, yet no vaccine exists. Although the bacteria use multiple strategies to evade the immune system, researchers still know little about how the body coordinates its defenses over time and across tissues.
Gonzalez said the study builds on two decades of work at UCSD.
Led by first-author Dr. Concepcion Sanchez, researchers in Gonzalez’s team from UCSD published an article in the Molecular & Cellular Proteomics revealing how the host coordinates the local and systemic immune defenses. The team used mass spectrometry-based proteomics to track protein changes in infected skin and spleen tissue over seven days.
“By comparing infected and healthy tissues, Dr. Sanchez could see exactly how the body responds at the functional level,” Gonzalez said.
They found that infection triggers an aggressive surge of immune proteins, simultaneously causing structural proteins to break down while activating tissue-repair processes. Their research demonstrates extensive remodeling, including rewiring cellular signaling, including changes in cellular signaling pathways such as mTOR signaling associated with inflammation and cellular stress.
In response to the host, bacteria secrete proteases like SpeB, which degrade the body’s complement immune proteins. They uncovered an increase of chitinase- like, or Chil proteins, over time. These proteins may help promote immune-cell infiltration at the infection site, which is important for tissue repair and infection control.
The researchers also used phosphoproteomics to identify signaling pathways altered during infection. In addition to showing how skin infection disrupts homeostasis with alterations in immune signaling, their phosphoproteomic analysis revealed coordinated but distinct signaling responses between local and systemic tissues such as the spleen.
Not only does this study provide a fundamental understanding of infection, but it also captures real tissue responses and direct interactions between host and pathogen. The findings may also guide the development of therapies targeting GAS infection.
Future studies will focus on validating biomarkers such as Chil proteins and pro-inflammatory cytokines, using gained knowledge to test Federal Drug Administration-approved drugs and exploring other infections.
“This research could enable earlier diagnosis, better treatment decisions, new drug targets and improved outcomes for patients with infections,” Gonzalez said.